The lifting of non-pharmaceutical measures preventing transmission of SARS-CoV-2 (and
other viruses, including influenza viruses) raises concerns about healthcare resources and …

Background: Quadrivalent influenza vaccines (QIVs) contain antigens derived from an additional
influenza type B virus as compared with currently used trivalent influenza vaccines (TIVs…

Background This systematic literature review aimed to summarize evidence for the added
value of drug sales data analysis for the surveillance of infectious diseases. Methods A search …

1 Abstract Europe is now considered as the epicenter of the SARS-CoV-2 pandemic,
France being among the most impacted country. In France, there is an increasing concern …

1 Abstract On March 16 2020, French authorities ordered a large scale lockdown to counter
the COVID-19 epidemic wave rising in the country, stopping non-essential economic, …

Hospital-acquired infections (HAIs), including emerging multi-drug resistant organisms,
threaten healthcare systems worldwide. Efficient containment measures of HAIs must mobilize …

Background The roll-out of COVID-19 vaccines is a multi-faceted challenge whose
performance depends on pace of vaccination, vaccine characteristics and heterogeneities in …

Background Prior economic evaluations of adult and adolescent vaccination strategies
against pertussis have reached disparate conclusions. Using static approaches only, previous …

Background Designed to overcome influenza B mismatch, new quadrivalent influenza vaccines
(QIVs) contain one additional B strain compared with trivalent influenza vaccines (TIVs). …

Background After one year of stop-and-go COVID-19 mitigation, in the spring of 2021
European countries still experienced sustained viral circulation due to the Alpha variant. As the …